Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

NCT06733441

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Stanford Cancer Institute Stanford, California, United States

Washington University School of Medicine St Louis, Missouri, United States

Memorial Sloan Kettering Cancer Center New York, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT06712810

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

NCT05940272

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +15 more
Locations: Memorial Sloan Kettering Cancer Center (All protocol activities) New York, United States

NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) New York, United States

View Trial Details

Recruiting

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

NCT05963971

Conditions: Acute Lymphoblastic Leukemia, Body Weight, Hematologic Diseases, +17 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

NCT07202091

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

NCT07202078

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

NCT07202065

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

NCT07202052

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation

NCT04679012

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Mount Sinai- Icahn School of Medicine New York, United States

Columbia University Medical Center New York, United States

Weill Cornell Medicine New York, United States

Ohio state University Columbus, Ohio, United States

View Trial Details

Recruiting

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma

NCT06997081

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions